Nasdaq nmra.

Member FINRA / SIPC / NYSE / NASDAQ / CBOE EDGX. Webull offers NMRA Ent Holdg (NMRA) historical stock prices, in-depth market analysis, NASDAQ: NMRA real-time stock quote data, in-depth charts, free NMRA options chain data, and a fully built financial calendar to help you invest smart. Buy NMRA stock at Webull. Nov 27, 2023 · NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor that Neumora is developing as a treatment for schizophrenia and other neuropsychiatric disorders. Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Neumora Therapeutics, Inc. Common Stock (NMRA) Pre-Market Stock Quotes - Nasdaq ...

View real-time NMRA stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ... WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced financial results for the third quarter ended September 30, 2023 and provided a general business update.

Nov 27, 2023 · NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment of schizophrenia WATERTOWN, Mass., Nov. 27, 2023 (GLOBE ... The latest price target for . Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on November 8, 2023.The analyst firm set a price target for $20.00 expecting NMRA to rise to within 12 ...

Nov 1, 2023 · Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ... SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 0.58. At the close of trading, the stock’s price was $20.71, to imply a decrease of -2.08% or -$0.44 in intraday trading. The SWTX share’s 52-week ...Andrey Tolkachev/iStock via Getty Images. Neumora Therapeutics ( NASDAQ: NMRA) stock dipped 4% in late afternoon trading Friday following a $250M IPO. Shares of the psychiatric drug developer ...Neumora Therapeutics, Inc. (NASDAQ: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the pricing of its initial public offering of ...

Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...

20 Nov 2023 ... NMRA:NSQNASDAQ. Neumora Therapeutics Inc. Actions. Add to watchlist; Add ... Its other product candidates include NMRA-511, NMRA-266, NMRA-NMDA, ...

Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...Neumora Therapeutics, Inc. Common Stock (NMRA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience …Nov 27, 2023 · 1.55. EBIT. -130.9. -237.31. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Neumora Therapeutics, Inc. (NMRA). See many years of revenue, expenses and ... Neumora Therapeutics, Inc. ( NASDAQ:NMRA – Get Free Report) Director Kristina Burow bought 43,082 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was ...

The company’s shares trade on the Nasdaq under the stock symbol “NMRA.” Neumora is a new-ish company, having emerged with a $400 million Series A round of financing in 2021 after its initial formation in 2019. But the company’s history goes back further. Neumora represents the combination of five acquisitions, each bringing drug ...Neumora Therapeutics (NASDAQ: NMRA), a biotech company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, went public on September 15th with ...Sep 21, 2023 · Investors can buy NMRA even cheaper than Gosebruch did, with shares changing hands as low as $10.01 at last check today -- that's 20.7% under Gosebruch's purchase price. VIDEO: Thursday 9/21 ... A. The latest price target for Tilray Brands ( NASDAQ: TLRY) was reported by Roth MKM on Friday, September 1, 2023. The analyst firm set a price target for 2.50 expecting TLRY to rise to within 12 ...Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) shares gapped up before the market opened on Wednesday .The stock had previously closed at $11.69, but opened at $12.14. Neumora ...

ImmunityBio (NASDAQ:IBRX) and Neumora Therapeutics (NASDAQ:NMRA) are both medical companies, but which is the superior stock?We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and …

The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by Cantor Fitzgerald on Wednesday, November 8, 2023. The analyst firm set a price target for 24.00 expecting CBAY to ...Quais ferramentas de análise técnica podem ser usadas para analisar Neumora Therapeutics, Inc.? Confira vários osciladores, médias móveis e outros indicadores técnicos no TradingView.NASDAQ:NMRA; Company Type For Profit. Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain ...US6409791000. Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action ...Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares fell 8% to $11.02. Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) fell 7.4% to $9.97. BeiGene, Ltd. (NASDAQ:BGNE) fell 7.2% to $193.86. B of A ...NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor that Neumora is developing as a treatment for schizophrenia and other neuropsychiatric disorders. “The ...On October 10, 2023, Geoff Meacham, an analyst at Bank of America Securities, commenced coverage on Neumora Therapeutics (NASDAQ:NMRA) by Analyst Coverage and Price Targets for Neumora Therapeutics - Best StocksNov 1, 2023 · WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ... Neumora Therapeutics (NASDAQ:NMRA) stock dipped 4% in late afternoon trading Friday following a $250M IPO. Shares of the psychiatric drug developer opened at $16.50 after being priced at $17 per ...

Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

Uncover the latest insider trading activity for Neumora Therapeutics, Inc. (NMRA). Know which insiders are buying and selling along with top shareholders and ownership breakdown. Dashboard Markets Discover Watchlist Portfolios Screener. Neumora Therapeutics, Inc. NasdaqGS:NMRA Stock Report. Mkt Cap: US$1.8b.

Neumora Therapeutics has raised a total of. $612M. in funding over 4 rounds. Their latest funding was raised on Oct 11, 2022 from a Series B round. Neumora Therapeutics is registered under the ticker NASDAQ:NMRA . Their stock opened with $16.50 in its Sep 15, 2023 IPO. Neumora Therapeutics is funded by 18 investors.Neumora Therapeutics Inc. (NASDAQ:NMRA)’s traded shares stood at 0.14 million during the last session. At the close of trading, the stock’s price was $11.91, to imply an increase of 1.88% or $0.22 in intraday trading. The NMRA share’s 52-week high remains $17.74, putting it -48.95% down since ...CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced financial results for the third quarter ended September 30, 2023 and provided a general business update.Learn more. See all brokers. View live Neumora Therapeutics, Inc. chart to track its stock's price action. Find market predictions, NMRA financials and market news.Uncover the latest insider trading activity for Neumora Therapeutics, Inc. (NMRA). Know which insiders are buying and selling along with top shareholders and ownership breakdown. Dashboard Markets Discover Watchlist Portfolios Screener. Neumora Therapeutics, Inc. NasdaqGS:NMRA Stock Report. Mkt Cap: US$1.8b.Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...WATERTOWN, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...1.55. EBIT. -130.9. -237.31. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Neumora Therapeutics, Inc. (NMRA). See many years of revenue, …Sep 28, 2023 · VinFast Auto Ltd. (NASDAQ:VFS) gained 13.6% to $12.73 following a report suggesting the company is planning to set up a manufacturing plant in India. Neumora Therapeutics, Inc. (NASDAQ:NMRA ... Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...

Neumora Therapeutics is a biotech company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker NMRA on the NASDAQ exchange. Neumora Therapeutics stock last closed at $11.69 , down 1.35% from the previous day, and has decreased N/A in one year.Sep 15, 2023 · The Watertown, MA-based Neumora Therapeutics ( NASDAQ: NMRA ), a Phase 3 biotech developing therapies for brain diseases has priced its initial public offering of 14.71 million shares of its ... Find the latest historical data for Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com.Learn more. See all brokers. View live Neumora Therapeutics, Inc. chart to track its stock's price action. Find market predictions, NMRA financials and market news.Instagram:https://instagram. tsls etf stockporter stasberryforex.com pros and conscollector car market Neumora Therapeutics Inc (NASDAQ: NMRA) gained 15.4% to $14.00 in pre-market trading. Neumora Therapeutics recently initiated a Phase 1 single ascending dose / multiple ascending dose study of ... how much does one bar of gold costgold mining inc Neumora Therapeutics press release (NASDAQ:NMRA): Q3 GAAP EPS of -$1.14 misses by $0.74. $519.5 million in cash, cash equivalents and marketable securities expected to support operations into 2026.1.55. EBIT. -130.9. -237.31. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Neumora Therapeutics, Inc. (NMRA). See many years of revenue, … cigna ppo vs epo Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Neumora Therapeutics, Inc. Common Stock (NMRA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US ...WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...